Pfizer’s updated COVID vaccine approved by Health Canada
Global News
The vaccine approval coincides with the emergence of two new COVID-19 variants within the country, and experts are warning about continued vigilance in public health measures.
Pfizer’s updated COVID-19 vaccine for the upcoming fall and winter months has been granted Health Canada approval.
Pfizer’s updated vaccine is approved for people six months and older.
This decision follows the recent approval of Moderna’s updated vaccine for all Canadians aged six months and older.
At the time of Moderna’s approval, Health Canada senior medical adviser Dr. Supriya Sharma said the department was actively reviewing submissions from Pfizer and Novavax for their vaccines targeting XBB.1.5.
“These submissions are being reviewed on a priority basis by dedicated scientific teams,” she said during a briefing on Sept. 12.
“Timing for the completion of these reviews depends on many factors. We will make decisions once we have thoroughly evaluated all of the required information.”
The vaccine approval coincides with the emergence of two new COVID-19 variants, BA.2.86 and EG.5, within the country, and experts are again warning about continued vigilance in public health measures.
“This vaccine is anticipated to provide a robust immune response that will be effective against the Omicron XBB.1.5 variant,” Sharma said.